J Infect Dis by Mbaeyi, Chukwuma et al.
Progress Toward Polio Eradication — Somalia, 1998–2013
Chukwuma Mbaeyi1, Raoul Kamadjeu1,2, Abdirahman Mahamud1, Jenna Webeck1, Derek 
Ehrhardt1, and Abraham Mulugeta2
1United States Centers for Disease Control and Prevention, Atlanta, Georgia, USA
2World Health Organization, Somalia Liaison Office, Nairobi, Kenya
Abstract
Since the 1988 resolution of the World Health Assembly to eradicate polio, significant progress 
has been made toward achieving this goal, with the result that only Afghanistan, Nigeria, and 
Pakistan have never successfully interrupted endemic transmission of wild poliovirus. However, 
one of the greatest challenges of the Global Polio Eradication Initiative has been that of 
maintaining the polio-free status of countries in unstable regions with weak healthcare 
infrastructure, a challenge exemplified by Somalia, a country in the Horn of Africa region. 
Somalia interrupted indigenous transmission of wild poliovirus in 2002, four years after 
establishing its national polio eradication programme. But political instability and protracted 
armed conflict, with significant disruption of the healthcare system, left the country vulnerable to 
two subsequent imported outbreaks of wild poliovirus. The first occurred during 2005–2007, 
resulting in over 200 cases of paralytic polio, while the second importation in 2013 is currently 
ongoing. Despite immense challenges, the country has a sensitive surveillance system that has 
facilitated prompt detection of outbreaks, but its weak routine immunization system means that 
supplementary immunization activities constitute the primary strategy for reaching children with 
polio vaccines. Conducting vaccination campaigns in a setting of conflict has been at times 
hazardous but the country’s polio programme has demonstrated resilience in overcoming many 
obstacles to ensure that children receive life-saving polio vaccines. Regaining and maintaining 
Somalia’s polio-free status will, however, depend on finding innovative and lasting solutions to 
the challenge of administering vaccines in a setting of ongoing conflict and instability.
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Somalia, a country located in the Horn of Africa, is an exemplar of some of the successes 
and enduring challenges of the Global Polio Eradication Initiative. A decade after the World 
Health Assembly resolved to eradicate polio (1, 2), the country established its own polio 
eradication programme in 1998. Four years later, in 2002, Somalia successfully interrupted 
indigenous transmission of wild poliovirus (WPV) (3), a remarkable accomplishment 
considering that the country has been embroiled in war and armed conflict since 1991 (4, 5). 
This success has been punctuated by two importations and subsequent outbreaks of wild 
poliovirus. The first occurred during 2005 – 2007, resulting in 228 cases of paralytic polio, 
but was successfully interrupted (6). The second is currently ongoing, having first been 
reported on May 9, 2013, when stool specimens from a 32-month-old girl with acute flaccid 
paralysis (AFP) from Banadir region tested positive for wild poliovirus (7).
Since the fall of the central government in 1991, the prevailing situation in Somalia has been 
characterized by continuing strife, armed conflict, and political instability (5). Lacking a 
central government, the country administers services through three relatively autonomous 
areas derived from its four geo-political zones i.e., South, Central, Northeast, and Northwest, 
which are further subdivided into 19 regions and over a hundred districts (Figure 1). The 
South and Central zones are administered by the Federal Government of Somalia; the 
Northwest zone constitutes the self-declared state of Somaliland; and the Northeast is 
administered as the semi-autonomous region of Puntland (8, 9). While the Northwest and 
Northeast zones of the country are relatively stable with intermittent areas of conflict, the 
South and Central zones remain under a fragile security situation, with several territories 
controlled by armed militia and factions opposed to the government (5). The impact of the 
unstable political situation is a severely weakened healthcare system, unable to meet the 
needs of a vulnerable population. This is the context in which the country’s polio eradication 
programme has had to carry out its activities, often under immense constraints and 
sometimes with danger to the lives of its polio workers (10). Guided by the four key 
strategies for polio eradication, i.e., surveillance, supplementary immunization, routine 
immunization and mop-up activities (2, 11), the country’s programme has demonstrated 
resilience in its commitment to the goal of polio eradication.
This paper describes the progress made by Somalia’s polio eradication programme over the 
past 15 years, highlighting pertinent challenges and obstacles that have been confronted 
during this period. We provide details of AFP surveillance and supplementary immunization 
activities (SIAs), as well as the constraints of administering routine immunization through 
the country’s weakened healthcare infrastructure. We describe how obstacles have been 
surmounted, intercurrent challenges, and strategies that have been devised to overcome 
them.
Methods
This country progress report was developed based on review and analysis of existing data 
and documents provided by the WHO Somalia Country Office.
Mbaeyi et al. Page 2













Acute Flaccid Paralysis (AFP) Surveillance
We reviewed and analyzed AFP surveillance records from January 1998 through October 
2013. Our analysis of AFP cases reported during this period focused on the following areas: 
the non-polio AFP rate; adequacy of stool specimen collection for case investigation; WPV 
incidence, including outbreaks occurring during this time period; and circulating vaccine-
derived poliovirus (cVDPV) incidence. AFP cases were analyzed for key demographic 
characteristics, such as age, sex, geographic location, as well as their immunity profile, i.e., 
number of oral polio vaccine (OPV) doses received, as documented based on parental recall. 
AFP cases that were neither WPV nor cVDPV were characterized as: 1.) compatible, if they 
lacked adequate stool specimens but had residual paralysis or a pattern of clinical 
presentation consistent with polio after 60 days of onset; 2.) discarded, if they had adequate 
stool specimens but tested negative for poliovirus or lacked adequate stool specimens and 
did not have residual paralysis or a pattern of clinical presentation consistent with polio after 
60 days of onset. Surveillance indicators were compared with standards stipulated by WHO 
guidelines, e.g., ≥2 non-polio AFP cases reported per 100,000 persons <15 years per year as 
an indicator of sensitive surveillance. Non-polio AFP rates were calculated based on 
discarded AFP cases and using denominators derived from UNDP estimates of the target 
population (children <15 years). We also calculated the proportion of AFP cases with 
adequate stool specimens, i.e., two specimens collected at least 24 hours apart within 14 
days of the onset of paralysis and arriving at the laboratory in good condition, and the non-
polio enterovirus isolation rate, to determine the quality of surveillance. AFP case status 
results were reported based on testing by the Regional Reference Laboratory in Nairobi, 
Kenya and the final determination for compatible and discarded cases was made by the 
National Polio Expert Committee.
Supplementary Immunization Activities (SIAs)
Using vaccination campaign records provided by the WHO Somalia Country Office, we 
assessed the quality of SIAs conducted in Somalia during 1998 through 2012. Since the 
South and Central zones are typically treated as one administrative block, planning and 
implementation of SIAs was done by dividing the country into three SIA zones: South 
Central, Northwest and Northeast. Hence, for each year, we summarized the number of SIAs 
carried out by zone and the number of districts reached during campaigns. We estimated the 
coverage levels achieved in areas where campaigns were conducted based on administrative 
data. For years in which data were collected on vaccine refusals (2006–2012), we estimated 
the proportion of children who could not be vaccinated on account of refusals. We also 
identified areas where SIAs could not be conducted (i.e., inaccessible areas) during the 
period under review.
Routine Immunization
Estimates of routine immunization coverage against polio in Somalia during 1998 through 
2012 were obtained from WHO and UNICEF official documents providing details of OPV3 
coverage (12, 13). These estimates were derived from coverage surveys and administrative 
data and compared with those reported by the government. Starting in 2009, the government 
has supplemented routine immunization coverage estimates with figures derived from Child 
Mbaeyi et al. Page 3













Health Days (CHDs) (13), a special intervention geared toward reaching children under five 
years with basic health services, including essential vaccines (9, 14).
Special Strategies
In addition to available AFP and SIA data, we reviewed field reports and other documents 
provided by the WHO Somalia Country Office in order to ascertain details of special 
strategies employed in carrying out polio eradication activities. We sought details on the 
choice of vaccines used during campaigns, the target age groups, methods of community 
engagement and social mobilization, and strategies for reaching children in hard-to-reach 
and inaccessible areas.
Data were analyzed using SAS 9.3 (SAS Institute Inc., Cary, NC, USA) and Microsoft Excel 
2010 (Microsoft Excel. Redmond, Washington: Microsoft, 2010). Owing to the long 
duration of the period under review, we reported statistical averages, with accompanying 
ranges where applicable, in lieu of actual estimates, for ease of presentation and 
interpretation of results.
Results
Country Demographics and Polio Staffing
Somalia has an estimated population of 10.5 million persons (15); approximately 2 million 
of these are children under five years of age. The South and Central zones are the most 
densely populated areas of the country, accounting for approximately two-thirds of the total 
population. Of the 19 regions, Banadir is the most densely populated and is home to the 
capital city of Mogadishu.
The polio eradication programme, led by the government and supported by WHO and 
UNICEF, is organized in such a way that there are two national and four zonal level 
coordinators, one for each zone. Each region has a polio eradication officer who coordinates 
activities at that level and directly supervises the district polio officers, who oversee the day-
to-day running of polio eradication activities at the district level. Additionally, several 
temporary polio workers, including vaccinators, social mobilizers, and logistical staff, are 
hired during the course of vaccination campaigns.
Surveillance
AFP Surveillance (Figure 2)—AFP surveillance in Somalia began in 1998. The majority 
of AFP cases reported in each of the years during 1998–2012 were male, with a consistent 
sex distribution of approximately three males to two females. The median age of AFP cases 
has been approximately two years of age over the past decade. The proportion of AFP cases 
that have not received OPV (zero-dose children) dropped from a high of 51% in 2000 to 8% 
in 2010. As of August 2013, the percentage of zero-dose AFP cases has again increased to 
38%.
During 1998–2012, the annual non-polio AFP rates ranged from 0.62 cases per 100,000 
persons <15 years of age in 1998 to 3.91 cases per 100,000 persons <15 years of age in 
2007. Beginning in 2001, non-polio AFP rates consistently exceeded the minimum standard 
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of 2 cases per 100,000 persons <15 years of age. As of August 2013, the country has 
achieved an annualized non-polio AFP rate of 5.86 cases per 100,000 persons <15 years of 
age for the year 2013.
With respect to other key surveillance indicators, the proportion of AFP cases reported 
within seven days of onset steadily improved through the years from a low of 19% in 1998 
to a high of 90% in 2011 and 2012. The percentage of AFP cases with adequate stool 
specimens also improved from 35% in 1999 to 99% in 2009 and 2010, and remained at 98% 
during 2011–2012. National estimates of the non-polio enterovirus isolation rate, an 
indicator of the quality of the reverse cold chain system for stool specimens, were 
consistently above the target of ≥10%, except in 2003, when the rate was 9%. However, the 
estimate in the Northwest zone fluctuated and was below the target level on several 
occasions during 1998–2012.
WPV Incidence (Figure 2)—The number of reported WPV cases increased from 12 in 
1998 to 96 in 2000, but sharply declined to seven and three cases in 2001 and 2002, 
respectively. Indigenous poliovirus transmission was interrupted in 2002, as no WPV cases 
were reported in Somalia in 2003 and 2004. In 2005, the country experienced a large, 
imported WPV outbreak which lasted until 2007 and resulted in 228 cases of paralytic polio, 
the majority of cases occurring during 2005. Somalia subsequently remained polio-free until 
April 2013, when another WPV importation initiated a widespread outbreak, which is 
currently ongoing and has led to 173 additional cases as of October 2013. Both polio 
outbreaks began in Banadir region, which also accounted for a majority of cases in the first 
outbreak and has so far reported the highest number of cases (69) in the current outbreak.
cVDPV Incidence (Figure 2)—During March 2008 through January 2013, 22 cVDPV 
cases were reported in Somalia. In 2008, two cases were reported, one each from Bari and 
Lower Shabelle regions. The number of cases increased to seven in 2009 but reduced again 
to two cases in 2010. In 2011, the cVDPV outbreak peaked, with nine cases reported, but 
subsequently declined in 2012, with only a single case reported. The most recent case was 
reported in January 2013. The country has now gone nine months without a single cVDPV 
case being reported. Of the 22 cases reported during 2008–2013, a majority were located in 
the contiguous and densely populated regions of Banadir (eight cases) and Lower Shabelle 
(six cases). All but two cases occurred in the South and Central zones; the other two cases 
occurred in the Northeast zone.
Immunization Activities
Routine Immunization (Figure 3)—Routine immunization across Somalia is 
administered through Maternal and Child Health (MCH) centers using the EPI schedule, in 
which OPV is administered at birth (OPV0), 6 weeks (OPV1), 10 weeks (OPV2) and 14 
weeks (OPV3). WHO-UNICEF estimates of OPV3 coverage remained consistently low 
(<50%) during 1998–2012. In 1998, OPV3 coverage was estimated at 35%; coverage 
estimates fluctuated between 30% and 40% until 2006, when it reached a low of 26%. 
Although OPV3 coverage estimates improved thereafter, reaching a high of 49% in 2010 
and 2011, they still remain way below the desired national coverage level of ≥90%.
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Beginning in 2009, Child Health Days (CHDs) have been carried out in Somalia as a means 
of delivering life-saving health interventions, including augmenting routine immunization 
services, as part of the Accelerated Young Child Survival (AYCS) strategy (14). During 
CHDs essential vaccines, such as measles-containing vaccine (MCV), diphtheria-pertussis-
tetanus vaccine (DPT) and OPV, are typically administered as part of a health package that 
also includes vitamin A and deworming tablets. CHD coverage estimates have been 
incorporated into the calculation of OPV3 coverage since 2009.
Polio SIAs (Figure 3, 4)—During 1998–2012, at least two rounds of SIAs targeting 
children under five years were conducted in at least two administrative zones in each year 
under review. The number of SIAs conducted ranged from two rounds in multiple years to 
nine rounds in 2007 for the Northwest and Northeast zones, except for 2004 when no SIAs 
were conducted in the Northwest zone. Similarly, the number of SIAs conducted in South 
Central Somalia during 1998–2012 ranged from two (multiple years) to ten in 2007 (Figure 
4). Examining the number of SIAs conducted annually in each of the three zones by smaller 
time intervals, five or fewer SIAs were conducted per year during 1998–2004, 8–10 SIAs 
during 2005–2007, and three or fewer SIAs were carried out during 2008–2012. SIAs in 
South Central Somalia also covered a much smaller median number of districts (29–35 
districts) per year during 2010–2012 compared with previous years (59–79 districts). 
Administrative SIA coverage estimates in all three zones was high – reaching or exceeding 
100% on several occasions – during the period under review. During 1998–2012, mean 
coverage estimates ranged from 73% (1999) to 106% (2011) in the Northeast zone; 86% 
(2002) to 105% (1999) in the Northwest zone; and 88% (2010) to 125% (1998) in South 
Central Somalia (Figure 3). For the years in which data were available (2006–2012), vaccine 
refusals were consistently <1%.
The onset of a WPV outbreak in 2013 has again been followed by an increase in the number 
of SIAs, as at least seven rounds of SIAs have been conducted in accessible districts in each 
zone of the country. However, at least 27 districts, all in South Central Somalia, have 
remained completely inaccessible for the conduct of vaccination campaigns owing to a ban 
imposed by anti-government elements. Among districts where campaigns have been 
conducted, some have only been partially accessible while others have posed significant 
security challenges to both vaccinators and recipients of the polio vaccine. Data from these 
campaigns is still being compiled but preliminary results suggest high (>90%) 
administrative coverage. Three more rounds of campaigns are planned from October 
through December.
Special Strategies—Trivalent OPV (tOPV) is the designated vaccine for routine 
immunization against polio and has been the most commonly used vaccine for immunization 
campaigns in Somalia. However, in response to the 2005–2007 WPV outbreak, monovalent 
OPV type 1 (mOPV1) was used during a majority of vaccination campaigns, with the 
country reverting back to tOPV for campaigns after the outbreak was successfully 
interrupted. With the onset of the 2013 WPV outbreak, bivalent OPV (bOPV) has be en the 
vaccine of choice for campaigns. Further, the target age group for vaccination has been 
expanded from the typical group of children under five years of age to children under ten 
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years and, in some instances, all age groups. Campaigns have also been synchronized with 
the neighboring countries of Kenya and Ethiopia, where feasible, just as was the case during 
the earlier outbreak.
To foster vaccine acceptance and high participation levels during campaigns, strong 
emphasis is placed on community engagement and social mobilization in the build-up to and 
during campaigns. This is often accomplished through mass media, social mobilizers/
announcers, and engagement of political and religious leaders within the community. For 
children in hard-to-reach and inaccessible areas, a special fixed-site/transit-point vaccination 
strategy has been established with the aim of vaccinating children commuting between 
accessible and inaccessible areas through permanent vaccination teams assigned to 
designated transit points.
Discussion
Over the past 15 years, Somalia’s polio eradication programme has been marked by 
significant triumphs and setbacks. Three major periods have defined the most critical events 
in the country’s progress toward polio eradication: 1998–2002, which culminated in the 
interruption of indigenous transmission of WPV; 2003–2007, during which the country was 
initially polio-free but, beginning in 2005, experienced an outbreak of WPV that was 
successfully interrupted in 2007; 2008–2013 (present), a period marked by, first, a 
prolonged outbreak of circulating vaccine-derived poliovirus and then, in 2013, the 
occurrence of a second outbreak of WPV.
During the years leading up to the interruption of WPV circulation in 2002, AFP 
surveillance activities were intensified, as were efforts to improve the population immunity 
through supplementary immunization activities. By 2001, the non-polio AFP rate had 
improved to 3.1 cases per 100,000 persons <15years, well above the benchmark of ≥2 cases 
per 100,000 persons <15 years for countries in regions where endemic circulation of polio 
has not been interrupted (16). Concurrently, at least four SIAs were conducted in each zone 
during the same year, a standard that was sustained the following year, when endemic 
transmission of wild poliovirus was halted. This was accomplished in spite of routine 
immunization coverage that was only at 40% in 2002 (12, 13) and ongoing conflict that 
made the conduct of vaccination campaigns hazardous (5, 10).
Somalia’s initial polio-free status was short-lived, as an imported WPV case in 2005 
precipitated a large and widespread outbreak that continued until March 2007 (6). 
Vulnerability to the outbreak may not only have been due to the enabling conditions created 
by continuing internal conflict and low routine immunization, but also owing to an apparent 
decline in the number of vaccination campaigns conducted in all three zones to three or 
fewer in 2004. This situation was promptly rectified in response to the outbreak, as an 
average of 8–10 campaigns were conducted annually in each zone during 2005–2007, with 
the then newly licensed mOPV1 (17) as the vaccine of choice in many of these campaigns. 
The superior immunogenicity of this type of OPV against WPV 1 relative to tOPV (18, 19), 
coupled with the number of campaigns conducted, greatly enhanced the ability of response 
activities to interrupt the outbreak. Of note, the country’s surveillance system remained 
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strong in the years prior to and during the outbreak, with non-polio AFP rates consistently 
≥2 per 100,000 persons <15 years and >80% of AFP cases having adequate stool specimens 
in each year during 2003–2007. The quality of surveillance not only enabled the country to 
detect the outbreak in the first place, it also provided assurance of its successful interruption.
A different form of challenge emerged after the 2005–2007 WPV outbreak. Two cases of 
circulating vaccine-derived poliovirus were reported from Bari and Lower Shabelle regions 
with dates of onset in 2008, reflecting gaps in population immunity against type 2 vaccine-
derived poliovirus. They were to become the first of 22 cases in a prolonged cVDPV 
outbreak that had its most recent case reported in January 2013 and spread to refugee camps 
in neighboring parts of Kenya (20). All cases identified during the outbreak have been type 
2 cVDPV, a scenario that could have arisen owing to the use of mOPV1 during most of the 
2005–2007 campaigns in a setting of low routine immunization coverage, thus allowing for 
the establishment of an immunity gap and population vulnerability to cVDPV type 2 (21). 
Another factor which could have accounted for the protracted nature of this outbreak was 
the ban imposed by anti-government elements on the conduct of vaccination campaigns in 
several districts of South Central Somalia. Beginning in 2009, when the ban was imposed, 
fewer districts were covered during campaigns in South Central Somalia, resulting in 
approximately one million children under ten years of age being unvaccinated against polio.
In the midst of prevailing challenges with conducting vaccination campaigns, the country’s 
AFP surveillance system detected an imported WPV type 1 case in May 2013 (date of 
paralysis onset: April 18, 2013), representing the first WPV case in Somalia in over six 
years. As of October 2013, 173 additional cases have been reported, representing a large and 
widespread outbreak, which is currently ongoing. As in the previous outbreak, the index 
case was detected in Banadir region, which has yet again turned out to be the epicenter of 
the current outbreak. Genetic sequencing has shown that the WPV outbreak strain is closely 
related to strains circulating in West Africa (7). Several factors could explain the occurrence 
of this outbreak. First, owing to the ban on vaccination campaigns, the large pool of 
susceptible children in South Central Somalia left the population highly vulnerable to a polio 
outbreak. Second, poor sanitation occasioned by high population density in urban areas and 
movement of internally displaced persons due to ongoing conflict created the conditions for 
ease of spread of WPV, given its fecal-oral route of transmission (22). Third, a major 
humanitarian crisis occurred in the Horn of Africa region in 2011, in which drought and 
famine left millions of Somali children malnourished and many families displaced (4, 23); 
factors that have further degraded the already weak population immunity profile against 
polio. All these factors occurring in a country with a dilapidated healthcare system and poor 
routine immunization coverage meant that it was only a matter of time for the country to 
experience another WPV outbreak.
The response to the current outbreak has again been swift, robust and innovative. Seven 
rounds of vaccination campaigns have been completed since the onset of the outbreak and 
three more are scheduled to take place before the end of the year. Bivalent OPV, owing to its 
superior immunogenicity (24), is being used for campaigns, target age groups have been 
expanded – sometimes to include all age groups – and special strategies, such as vaccination 
at transit points and cross border sites, are being implemented to reach children in areas that 
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are inaccessible for the conduct of campaigns. Preliminary results suggest high coverage in 
areas where vaccination campaigns have been conducted and monitored. The frequency and 
quality of these campaigns, coupled with the intensification of surveillance activities, gives 
reason for cautious optimism that Somalia will again interrupt WPV transmission. If again 
achieved, maintaining Somalia’s polio-free status will depend on finding strategies to 
deliver polio vaccines on a consistent basis in a setting of ongoing conflict and a country 
with severely weakened healthcare infrastructure.
Acknowledgements
We acknowledge the support of Ali Abdi Hassan and Carolyne Gathenji with compiling and updating the databases 
used in the preparation of this manuscript.
Funding Sources/Disclaimer: None. This manuscript was prepared as part of the official duties of the authors at 
the US Centers for Disease Control and Prevention and World Health Organization, Somalia Liaison Office. 
However, the findings and conclusions in this paper are those of the authors and do not necessarily represent the 
official position of the organizations they work for.
References
1. World Health Assembly. [Accessed September 16, 2013] WHA Resolution 41.28. 1988. Available 
at: http://www.polioeradication.org/content/publications/19880513_resolution.pdf
2. Hull HF, Birmingham ME, Melgaard B, Lee JW. Progress toward global polio eradication. J Infect 
Dis. 1997; 175(Suppl 1):S4–9. [PubMed: 9203684] 
3. CDC. Progress toward poliomyelitis eradication--Ethiopia, Somalia, and Sudan, January 2002-
August 2003. MMWR Morb Mortal Wkly Rep. 2003; 52(44):1076–9. [PubMed: 14603185] 
4. Mahomed Z, Moolla M, Motara F, Laher A. A Somalia mission experience. S Afr Med J. 2012; 
102(8):659–660. [PubMed: 22831938] 
5. Grunewald F. Aid in a city at war: the case of Mogadishu, Somalia. Disasters. 2012; 36(S1):S105–
S125. [PubMed: 22687153] 
6. World Health Organization. Somalia is again polio-free. Wkly Epidemiol Rec. 2008; 83(14):117–8. 
[PubMed: 18389556] 
7. CDC. Notes from the field: outbreak of poliomyelitis--Somalia and Kenya, May 2013. MMWR 
Morb Mortal Wkly Rep. 2013; 62(23):484. [PubMed: 23760191] 
8. Kohler JC, Pavignani E, Michael M, Ovtcharenko N, Murru M, Hill PS. An examination of 
pharmaceutical systems in severely disrupted countries. BMC International Health and Human 
Rights. 2012; 12:34. [PubMed: 23217184] 
9. Kamadjeu R, Assegid K, Naouri B, Mirza IR, Hirsi A, Mohammed A, Omer M, Dualle AH, 
Mulugeta A. Measles control and elimination in Somalia: the good, the bad, and the ugly. J Infect 
Dis. 2011; 204(Suppl 1):S312–7. [PubMed: 21666179] 
10. Bower H. Arming the population against polio in Somalia. Lancet. 2000; 356(9225):229. 
[PubMed: 10963209] 
11. Global Polio Eradication Initiative. [Accessed September 16, 2013] Strategic Plan 2010–2012. 
Available at: http://www.polioeradication.org/Portals/0/Document/StrategicPlan/
StratPlan2010_2012_ENG.pdf
12. WHO. [Accessed September 16, 2013] WHO vaccine-preventable diseases: monitoring system. 
2013 global summary. Available at: http://apps.who.int/immunization_monitoring/
globalsummary/coverages?c=SOM
13. WHO. [Accessed September 16, 2013] Somalia: WHO and UNICEF estimates of immunization 
coverage: 2012 revision. Available at: http://www.who.int/immunization_monitoring/data/som.pdf
14. Mirza IR, Kamadjeu R, Assegid K, Mulugeta A. Somalia: supporting the child survival agenda 
when routine health service is broken. J Infect Dis. 2012; 205(Suppl 1):S126–33. [PubMed: 
22315380] 
Mbaeyi et al. Page 9













15. United Nations, Population Division. The World Population Prospects - the 2012 revision. New 
York: 2013. 
16. CDC. Evaluating Surveillance Indicators Supporting the Global Polio Eradication Initiative, 2011–
2012. MMWR Morb Mortal Wkly Rep. 2013; 62(14):270–4. [PubMed: 23575241] 
17. Farag MM. Licensing of monovalent OPV1 vaccine. Biologicals. 2006; 34(2):145–9. [PubMed: 
16672188] 
18. Grassly NC, Wenger J, Durrani S, Bahl S, Deshpande JM, Sutter RW, Heymann DL, Aylward RB. 
Protective efficacy of a monovalent oral type 1 poliovirus vaccine: a case-control study. Lancet. 
2007; 369(9570):1356–62. [PubMed: 17448821] 
19. Jenkins HE, Aylward RB, Gasasira A, Donnelly CA, Abanida EA, Koleosho-Adelekan T, Grassly 
NC. Effectiveness of immunization against paralytic poliomyelitis in Nigeria. N Engl J Med. 2008; 
359(16):1666–74. [PubMed: 18923171] 
20. CDC. Update on vaccine-derived polioviruses— worldwide, April 2011–June 2012. MMWR. 
2012; 61:741–6. [PubMed: 22992572] 
21. Kew OM, Sutter RW, de Gourville EM, Dowdle WR, Pallansch MA. Vaccine-derived polioviruses 
and the endgame strategy for global polio eradication. Annu Rev Microbiol. 2005; 59:587–635. 
[PubMed: 16153180] 
22. Fine PE, Carneiro IA. Transmissibility and Persistence of Oral Polio Vaccine Viruses: Implications 
for the Global Poliomyelitis Eradication Initiative. Am J Epidemiol. 1999; 150(10):1001–1019. 
[PubMed: 10568615] 
23. Loewenberg S. Humanitarian response inadequate in Horn of Africa crisis. Lancet. 2011; 
13(378(9791)):555–8. [PubMed: 21847804] 
24. Sutter RW, John TJ, Jain H, Agarkhedkar S, Ramanan PV, Verma H, Deshpande J, Singh AP, 
Sreevatsava M, Malankar P, Burton A, Chatterjee A, Jafari H, Aylward RB. Immunogenicity of 
bivalent types 1 and 3 oral poliovirus vaccine: a randomised, double-blind, controlled trial. Lancet. 
2010; 376(9753):1682–8. [PubMed: 20980048] 
Mbaeyi et al. Page 10














Map of Somalia Showing Geopolitical (Administrative) Zones and Regions
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Epidemic Curve of AFP Cases in Somalia with Line Graph of Non-Polio AFP Rate during 
1998–2013
Abbreviations and AFP Case Definitions
AFP: Acute flaccid paralysis
WPV: Wild poliovirus
cVDPV: Circulating vaccine-derived poliovirus
npAFP: Non-polio AFP
Compatible: AFP cases lacking adequate stool specimens but having residual paralysis or a 
pattern of clinical presentation consistent with polio after 60 days of onset
Discarded: AFP cases with adequate stool specimens but testing negative for poliovirus, or 
lacking adequate stool specimens and not having residual paralysis or a pattern of clinical 
presentation consistent with polio after 60 days of onset
Pending: AFP cases pending final classification
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Bar Graph Showing Immunity Profile of AFP Cases with Line Graphs of Routine and 
Supplementary Immunization (Mean) Coverage, Somalia 1998–2012.
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Distribution of Polio Supplementary Immunization Activities (SIAs) by Year and Zone, 
Somalia 1998–2012.
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